Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-045652
Filing Date
2025-05-20
Accepted
2025-05-20 08:00:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10006
  Complete submission text file 0001213900-25-045652.txt   11778
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Subject) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-78785 | Film No.: 25966188
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address ARGAMAN 14 SHIMSHIT L3 17906
Business Address
YANAY YAKY (Filed by) CIK: 0001402539 (see all company filings)

Type: SCHEDULE 13D/A